PSUSA/00010808/202203 - periodic safety update report single assessment
Amoxicillin
PSUSA
Human
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Erythromycin (systemic use) - List of nationally authorised medicinal products - PSUSA/00010808/202203
English (EN) (198.1 KB - PDF)
Erythromycin (systemic use) - Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation - PSUSA/00010808/202203
English (EN) (135.72 KB - PDF)
български (BG) (125.94 KB - PDF)
español (ES) (127.87 KB - PDF)
čeština (CS) (119.84 KB - PDF)
dansk (DA) (118.5 KB - PDF)
Deutsch (DE) (135.84 KB - PDF)
eesti keel (ET) (133.42 KB - PDF)
ελληνικά (EL) (126.62 KB - PDF)
français (FR) (134.57 KB - PDF)
hrvatski (HR) (133.87 KB - PDF)
íslenska (IS) (138.04 KB - PDF)
Gaeilge (GA) (124.52 KB - PDF)
italiano (IT) (133.35 KB - PDF)
latviešu valoda (LV) (147.51 KB - PDF)
lietuvių kalba (LT) (136.96 KB - PDF)
magyar (HU) (138.66 KB - PDF)
Malti (MT) (136.63 KB - PDF)
Nederlands (NL) (129.74 KB - PDF)
norsk (NO) (126.6 KB - PDF)
polski (PL) (139.47 KB - PDF)
português (PT) (128.47 KB - PDF)
română (RO) (129.52 KB - PDF)
slovenčina (SK) (179.36 KB - PDF)
slovenščina (SL) (128.39 KB - PDF)
Suomi (FI) (127.32 KB - PDF)
svenska (SV) (128.23 KB - PDF)